Best Grants for Cancer Nonprofits in Oklahoma

Underinsured U.S. patients being treated for chronic lymphocytic leukemia can receive up to US $8,000 to cover prescription drug copays and Medicare Part B premiums. With a mission to reduce financial barriers to care, HealthWell Foundation provides this support, which may benefit cancer-focused organizations in Oklahoma assisting eligible patients.

Individuals being treated in the U.S. for cancer-related behavioral health conditions can receive up to US $2,000 in financial assistance for prescriptions, counseling, psychotherapy, and transportation costs. Healthwell Foundation helps underinsured patients with eligible insurance in Oklahoma and nationwide cover copays and other cost-shares for prescribed behavioral health services.

Underinsured individuals being treated for amyloidosis-related cancer in Oklahoma can receive up to US $8,000 to cover prescription drug copays and Medicare Part B premiums. Healthwell Foundation provides this U.S.-wide support to help patients afford covered amyloidosis treatments, which may benefit cancer-focused nonprofits assisting eligible patients with access to care.

Nonprofit, tax-exempt 501(c)(3) educational or research institutions in the U.S., including those in Oklahoma, can seek funding to develop non-animal methods for childhood cancer research. With a mission to advance humane science, Alternatives Research & Development Foundation provides US $210,000 for pre-clinical projects that improve childhood cancer knowledge or treatment using non-animal models.

Professional elderly blues musicians in Oklahoma facing emergency medical or basic living expenses can receive assistance for costs like doctor visits, transportation to cancer treatments, home care, utilities, or burial needs. Pinetop Perkins Foundation provides this U.S.-wide support, offering US $500 paid directly to creditors rather than to individuals.

With a mission to improve patient-centered healthcare decisions, the Patient-Centered Outcomes Research Institute provides Oklahoma cancer and oncology organizations with funding for comparative clinical effectiveness research across the cancer care continuum. Researcher–community partnerships in the U.S. may apply for up to Up to US $13,000,000 to address screening barriers, treatment delivery, or survivor follow-up needs.

Cancer researchers proposing pilot projects to improve prevention, early detection, treatment, or survivorship care in high-burden populations across the U.S., including Oklahoma, can apply for up to US $50,000 in support. Focused on translational, interdisciplinary work, Indiana Clinical and Translational Sciences Institute backs IUSCCC member-led studies that address real-world barriers to better cancer outcomes.

Oklahoma cancer and health research organizations conducting retrospective comparative clinical effectiveness studies can access funding through the Patient-Centered Outcomes Research Institute. Projects must leverage existing data sources and address at least one topic such as cancer, maternal health, mental and behavioral health, metabolic disease, pain, substance use, rare diseases, sensory health, or intellectual and developmental disabilities, with awards up to US $2,000,000.

Cancer research institutions and academic medical centers conducting translational oncology studies in Oklahoma and other U.S. locations can seek funding to advance organ-specific or biologically related cancer prevention, detection, diagnosis, and treatment. National Institutes of Health SPORE P50 grants support state-of-the-art human biology-based research projects that aim to reach a translational human endpoint within the grant period, with awards of US $25,000,000.

Graduating high school seniors and healthcare professionals pursuing oncology or hematology education in Central or Southern Illinois can receive tuition or professional development support through the Cancer Care Specialists of Illinois Scholarship. Heart of Illinois Community Foundation funds schooling, certifications, and conferences, and Oklahoma cancer organizations with eligible staff or students connected to these Illinois counties may benefit.

Focused on cancer research, this award invites Oklahoma radiation oncology clinician-scientists at U.S. academic or eligible nonprofit institutions to seek multi-year career development funding. The American Society for Radiation Oncology and the American Cancer Society co-fund this Clinician Scientist Development Grant, providing US $135,000 per year to help clinicians become independent investigators while maintaining clinical practice.

Practicing radiation oncologists conducting cancer research in the U.S., including Oklahoma, can apply for the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Award, which provides US $729,000 over three to five years. This American Society for Radiation Oncology partnership supports clinician-scientists studying questions across the cancer care continuum.

Oklahoma cancer-focused medical schools, hospitals, patient advocacy groups, and 501(c)(3) nonprofits can access funding through Incyte for healthcare education, patient information, and related programs. Incyte supports initiatives that improve access to cancer and disease information for students, healthcare providers, patients, and caregivers, including medical education and professional training activities.

Cancer-focused medical schools, hospitals, patient advocacy groups, and other eligible nonprofits in Oklahoma can seek support for healthcare education, patient care, and related programs. Focused on improving the lives of patients with cancer and other diseases, Incyte provides charitable contributions, sponsorships, and memberships to organizations ensuring access to vital healthcare information.

Cancer research institutions and oncology-focused organizations in Oklahoma and across North America can seek funding for studies on combining radiation therapy and immunotherapy, with typical awards of US $50,000 - US $100,000. With a mission to advance innovative cancer treatment, Radiation Oncology Institute supports projects on treatment optimization, toxicity reduction, education, and access to combined therapies.

The Radiation Oncology Institute (ROI) Innovation Awards, offered by the American Society for Radiation Oncology, aim to accelerate innovative ideas in radiation therapy. Currently accepting applications for the 2026 awards, the program focuses on optimizing the combination of radiation therapy and immunotherapy to enhance cancer treatment outcomes. By supporting practical research, ROI strives to transform clinical practices and improve patient care in the fight against cancer.

Pfizer is offering a grant opportunity for independent medical education initiatives focused on Muscle Invasive Bladder Cancer (MIBC). This program aims to address the current knowledge gaps among healthcare professionals regarding emerging treatment data and its potential impact on clinical practices. By collaborating with Astellas, Pfizer seeks proposals that enhance awareness and understanding of the evolving MIBC landscape, ultimately improving patient outcomes in this critical area of unmet medical need.

The Joyce Bytof Memorial Cancer Survivors Scholarship, established by Joyce Bytof in collaboration with the American Cancer Society, supports childhood cancer survivors graduating from specific Wisconsin high schools. This scholarship aims to assist them in pursuing higher education despite the financial and academic challenges posed by their experiences. Joyce's legacy continues to inspire hope and resilience among young survivors as they strive for academic success and a brighter future.

The AACR-Torrey Coast Foundation Transpacific Gastric and Esophageal Cancer Research Partnership Grant supports innovative research on upper gastrointestinal malignancies, which are responsible for over one million deaths globally in 2023. This grant encourages collaboration between U.S. and Asian institutions, focusing on resistance, metastasis, and novel treatment strategies. Proposals should detail plans for clinical translation and are open to researchers at all career stages, especially those new to upper GI cancer research.

Bristol Myers Squibb Foundation Inc supports independent medical education to enhance healthcare professional competence and improve patient health outcomes. Their mission is to be a global leader in innovative medical education, focusing on evidence-based activities that address critical gaps in knowledge. By fostering excellence in healthcare, they aim to ensure measurable improvements in performance and patient outcomes across various disease areas.

The National Cancer Institute (NCI) invites applications for the validation of biomarkers and assays for cancer detection and treatment. This funding opportunity allows for biphasic or monophasic applications to support both analytical and clinical validation phases. Successful projects will leverage human specimens to develop assays that enhance cancer treatment and prevention, ensuring multidisciplinary collaboration among scientists and clinicians. This initiative aims to improve cancer management through reliable and clinically validated tools.

The American Heart Association is seeking proposals to study the prevalence and treatment of cardiovascular, kidney, and metabolic diseases among cancer patients and survivors. Given the over 16.7 million cancer survivors in the U.S., this research aims to highlight critical health disparities, identify treatment modalities, and explore shared risk factors. Applications focusing on underrepresented populations and utilizing real-world data sources are especially encouraged, aiming to improve health outcomes in this vulnerable group.

The Juan Diego Guadiana Legacy Foundation Scholarship supports students from Las Cruces High School or Doña Ana County, especially those affected by cancer treatment or pursuing health-related fields. This scholarship is open to various backgrounds, including BiPOC and LGBTQIA+ communities. The foundation aims to empower students at different educational stages, ensuring they have the resources necessary to thrive in their academic and professional journeys.

The Vince Lombardi Cancer Foundation (VLCF) has played a pivotal role in cancer research and education since its inception in 1971, raising over $21 million to support innovative treatments and compassionate care. This private foundation invites applications from recognized healthcare institutions, focusing on funding scientific and medical fellowships. VLCF is dedicated to preventing cancer and improving patient care, ensuring that the spirit of excellence continues in the fight against this disease.

The NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08) aims to enhance the careers of clinical scientists committed to cancer research. This NIH-supported program provides protected time for research and encourages underrepresented individuals in health-related sciences. With deadlines spanning from 2025 to 2027, the program focuses on training and developing the skills necessary to compete for significant research funding and address health disparities in cancer research.

This initiative aims to support research interventions targeting disparities in liver diseases and liver cancer among underserved populations in the U.S. It encourages innovative approaches to reduce health inequities and improve health outcomes. The funding opportunity is available through various deadlines for both standard and renewal applications, promoting multi-level strategies to address these critical health issues effectively.

The National Cancer Institute (NCI) invites applications for the Toward Translation of Nanotechnology Cancer Interventions (TTNCI) program. This funding opportunity focuses on advanced pre-clinical research aimed at developing nanotechnology-based cancer diagnostics and therapeutics. TTNCI awards will support the maturation of innovative nanomedicines using nanoparticles and nano-devices, enhancing cancer treatment efficacy. Successful projects will progress towards further NCI translational programs, such as the NExT initiative.